Key result
A 65-year-old patient developed severe thrombocytopenia, a rare complication, while receiving rosuvastatin treatment.
Case Report (n=1)
Rosuvastatin treatment can rarely be complicated by severe thrombocytopenia, highlighting the need for clinical vigilance.
Supports vigilance for thrombocytopenia on rosuvastatin; leaves open true incidence and causality.
Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature.
No takes yet. Share an insight, caveat, or question.
Vrettos et al. (2010) conducted a case report in Severe thrombocytopenia (n=1). Rosuvastatin was evaluated on Severe thrombocytopenia. A 65-year-old patient developed severe thrombocytopenia, a rare complication, while receiving rosuvastatin treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: